Abstract
Background and aims
Up to 45% of colorectal cancer (CRC) patients will develop local recurrence or metastasis following curative resection. The latter is due to cells shed from the primary carcinoma prior to or during surgery. The aim of this study was to contribute toward a “rational”-approach for detecting these disseminated tumor cells (DTC) using a combination of independent markers and detection methods.
Patients/methods
Liver, lymph node, and bone marrow samples from 246 CRC patients were screened for DTC using three markers: mutated K-ras was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and cytokeratin 20 (CK20) and guanylylcyclase C (GCC), indicating circulating epithelial cells, were tracked by nested reverse-transcription (RT) PCR.
Results
The rate of positive findings of the individual markers (CK20: 88%; GCC: 88%; K-ras: 67%) and their combinations (88–50%) was significantly higher in biopsies from liver metastases than in liver samples from patients without evident distant metastasis (M0; p<0.03). The detection rate of individual markers (except GCC) was also significantly elevated in inconspicuous liver tissue adjacent to metastasis compared with specimens from M0 patients. When using the concomitant detection of all three markers as criterion for DTC in the liver of M0 patients, however, no patient was DTC-positive. Therefore, the concomitant presence of the two CEC markers (CK20 plus GCC) and/or the presence of mutated K-ras were preferred for a combined evaluation, which resulted in a 24% detection rate for biopsies from both liver lobes. This translates into 39% of M0 patients with at least one positive liver biopsy.
Conclusion
Our results suggest that the concomitant detection of CK20 plus GCC and/or the presence of mutated K-ras are a rational approach for tracking CEC/DTC in CRC patients.
Similar content being viewed by others
References
Bosman FT (1995) Prognostic value of pathological characteristics of colorectal cancer. Eur J Cancer 31A:1216–1221
Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, Laurie JA (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27–35
Kune GA, Kune S, Field B, White R, Brough W, Schellenberger R, Watson LF (1990) Survival in patients with large-bowel cancer. Dis Colon Rectum 33:938–946
Cagir B, Gelmann A, Park J, Fava T, Tenkelevitch A, Bittner EW, Weaver EJ, Palazzo JP, Weinberg D, Fry RD, Waldmann SA (1999) Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer. Ann Intern Med 131:805–812
Conzelmann M, Dieterle CP, Linnemann U, Berger MR (2003) Cytokeratin 20 and guanylylcyclase C mRNA is largely present in lymph node and liver specimens of colorectal cancer patients. Int J Cancer 107:617–628
Dieterle CP, Conzelmann M, Linnemann U, Berger MR (2004) Investigation of isolated tumor cells by PCR-RFLP detection of K-ras mutations in tumor, mucosa, liver, lymph node and bone marrow samples of 199 colorectal cancer patients. Clin Cancer Res 10:641–650
Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S (1998) Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 68:34–40
Lassmann S, Bauer M, Rosenberg R, Nekarda H, Soong R, Rüger R, Höfler H, Werner M (2004) Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression. Int J Colorectal Dis 19:87–94
Miyake Y, Yamamoto H, Fujiwara Y, Ohue M, Sugita Y, Tomita N, Sekimoto M, Matsuura N, Shiozaki H, Monden M (2001) Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. Clin Cancer Res 7:1350–1357
Nakamori S, Kameyama M, Furukawa H, Takeda O, Sugai S, Imaoka S, Nakamura Y (1997) Genetic detection of colorectal cancer cells in circulation and lymph nodes. Dis Colon Rectum 40 [Suppl]:29–36
Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, Fujunaga H, Miyake Y, Ikenaga M, Ikeda M, Sekimoto M, Mtsuura M, Monden M (2002) Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 20:4232–4241
Rosenberg R, Hoos A, Mueller J, Baier P, Stricker D, Werner M, Nekarda H, Siewert JR (2002) Prognostic significance of cytokeratin 20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol 204:1049–1055
SaltoTellez M, Kong SL, Leong APK, Koay ESC (2003) Intrinsic variability in the detection of micrometastases in lymph nodes for re-staging of colorectal cancer: effect of individual markers and tissue samples. Eur J Cancer 39:1234–1241
Yun K, Merrie AEH, Gunn J, Phillips LV, McCall J (2000) Keratin 20 is a specific marker of submicroscopic lymph node metastases in colorectal cancer: validation by K-ras mutations. J Pathol 191:21–26
Bustin SA, Siddiqi S, Ahmed S, Hands R, Dorudi S (2004) Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 108:412–417
Bustin SA, Gyselman VG, Williams NS, Dorudi S (1999) Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 7911/7912:1813–1820
Yamaguchi K, Takagi Y, Aoki S, Futamura M, Saji S (2000) Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 232:58–65
Guller U, Zajac P, Schnider A, Boesch B, Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U, Harder F, Heberer M, Marti WR (2002) Disseminated single tumor cells detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer. Ann Surg 236:768–776
Wharton RQ, Jonas SK, Glover C, Khan ZAJ, Klokouzas A, Quinn H, Henry M, Allen-Mersh TG (1999) Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples. Clin Cancer Res 5:4158–4163
Vlems FA, Diepstra JHS, Cornelissen IMHA, Ligtenberg MJL, Wobbes T, Punt CJA, van Krieken JHJM, Ruers TJM, van Muijen GNP (2003) Investigations for a multi-marker RT-PCR to improve sensitivity of disseminated tumor cell detection. Anticancer Res 23:179–186
Fujita S, Kudo N, Takayuki A, Moriya Y (2001) Detection of cytokeratin 19 and 20 mRNA in peripheral blood from colorectal cancer patients and their prognosis. Int J Colorectal Dis 16:141–146
Hardingham JE, Hewett PJ, Sage RE, Finch JL, Nutall JD, Kotasek D, Dobrovic A (2000) Molecular detection of blood-borne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer 89:8–13
Bosch B, Guller U, Schnider A, Maurer R, Harder F, Metzger U, Marti WR (2003) Perioperative detection of disseminated tumor cells is an independent prognostic factor in patients with colorectal cancer. Br J Surg 90:882–888
Kienle P, Koch M, Autschbach F, Benner A, Treiber M, Wannenmacher M, von Knebel Doeberitz M, Büchler MW, Herfarth C, Weitz J (2003) Decreased detection rate of disseminated tumor cells of rectal cancer patients after preoperative chemoradiation. Ann Surg 238:324–331
Aoki S, Takagi Y, Hayakawa M, Yamaguchi K, Futamura M, Kuneida K, Saji S (2002) Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients. J Exp Clin Cancer Res 21:555–562
Linnemann U, Schimanski CC, Gebhardt C, Berger MR (2004) Prognostic value of disseminated colorectal tumor cells in the liver: results of follow-up examinations. Int J Colorectal Dis 19:380–386
Schimanski CC, Linnemann U, Berger MR (1999) Sensitive detection of k-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res 59:5169–5175
Yokoyama N, Shirai Y, Ajioka Y, Nagakura S, Suda T, Hatakeyama K (2002) Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases. Cancer 94:1642–1647
Klump B, Nehls O, Okech T, Hsieh CJ, Gaco V, Gittinger FS, Sarbia M, Borchard F, Greschniok A, Gruenagel HH, Porschen R, Gregor M (2004) Molecular lesions in colorectal cancer: impact on prognosis? Int J Colorectal Dis 19:23–42
Carrithers SL, Barber MT, Biswas S, Parkinson SJ, Park PK, Goldstein SD, Waldmann SA (1996) Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissue. Proc Natl Acad Sci USA 93:14827–14832
Vlems FA, Ruers TJM, Punt CJA, Wobbes T, van Muijen GNP (2003) Relevance of disseminated tumor cells in blood and bone marrow of patients with solid epithelial tumors in perspective. Eur J Surg Oncol 29:289–302
Nordgard O, Aloysius TA, Todnem K, Heikkila R, Ogreid D (2003) Detection of lymph node micrometastases in colorectal cancer. Scand J Gastroenterol 2:125–132
Jung R, Krueger W, Hosch S, Holweg M, Kroeger N, Gutensohn K, Wagener C, Neumaier M, Zander AR (1998) Specificity of reverse transcriptase polymerase chain reaction assays designed for the detection of circulating cancer cells is influenced by cytokines in vivo and in vitro. Br J Cancer 789:1194–1198
Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas. Am J Pathol 140:427–447
Tot T (2002) Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 38:758–763
Tot T (1999) Adenocarcinomas metastatic to the liver. Cancer 85:171–177
Baisse B, Bouzourene H, Saraga EP, Bosman FT, Benhattar J (2001) Intratumoral genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 93:346–352
Schimanski CC, Linnemann U, Galle PR, Arbogast R, Berger MR (2003) Hepatic disseminated tumor cells in colorectal cancer UICC stage IV patients: prognostic implications. Int J Oncol 23:791–796
Safi F, Beyer HG (1993) The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 17:417–424
August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324
Yamamoto N, Kato Y, Yanagisawa A, Ohta H, Takahashi T, Kitagawa T (1997) Predictive value of genetic diagnosis for cancer micrometastasis. Cancer 80:1393–1398
Clarke GA, Ryan E, Crowe JP, O’Keane JC, MacMathuna P (2001) Tumor derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer related death. Int J Colorectal Dis 16:108–111
Edler L, Ittrich C (2003) Biostatistical methods for the validation of alternative methods for in vitro toxicity testing. Altern Lab Anim 31:5–41
Acknowledgement
This work was supported by the Dr Ernst and Anita Bauer Stiftung.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conzelmann, M., Linnemann, U. & Berger, M.R. Molecular detection of clinical colorectal cancer metastasis: how should multiple markers be put to use?. Int J Colorectal Dis 20, 137–146 (2005). https://doi.org/10.1007/s00384-004-0640-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-004-0640-2